trends & perspectives in clinical research

goBalto Chromosome

More Collaboration with Investigative Sites: Less Technology Overload Delivers Transparency and Efficiencies

by Craig Morgan

Years of lamenting the inefficiencies of paper-driven clinical trials have led to a stunning revolution — the sector is now awash in technology, but it is not at all clear that this is a positive development.

White Paper: More Collaboration with Investigative Sites - Less Technology Overload Delivers Transparency and Efficiencies

Investigative sites are being inundated with technologies, most of which do not communicate with each other, leaving end users to log into and out of numerous portals to enter or review information to conduct clinical trials. This is no easy task as there are portals for clinical trial operations, trial data, lab results, imaging results, patient diaries, institutional review boards, and more. And despite the crush of new technologies, there is little evidence that they are helping sponsors and contract research organizations (CROs) collaborate with sites, or enabling them to become more competitive through improved clinical trial performance. One telling statistic is that on average, 11% of sites are never activated, a factor that has not changed in more than a decade. Also, study startup time, widely considered a leading cause of lengthy cycle times, has stagnated for twenty years.

These performance challenges are a top concern for sponsors and CROs who are increasingly aware that sites want feedback about their study conduct, and they want it during the trial, when they still have an opportunity to make corrections if they are veering off course. In particular, sites want to know what is expected of them, plus transparency on performance metrics beyond how they stack up to the competition in meeting patient enrollment targets.

Cloud-based tools that facilitate the flow of information among stakeholders help to create the transparent atmosphere that sites are looking for. With the aid of workflows that identify the tasks awaiting completion, the workload at the site is simplified, sites become more engaged, and sponsors and CROs can more easily share performance results with sites, building a foundation for a mutually beneficial collaboration.

Beth Harper
Clinical Performance Partners
"Sites want to feel more empowered by learning how they are doing relative to other sites in terms of enrollment, timeliness of case report form entry, query resolution and other metrics. Also, if they are struggling, they want to know they aren't alone. More importantly, how can sites improve based on how their successful peers are performing?"
Shaun O'Conor
Director of Regulatory and Source
"Historically, getting feedback from sponsors and CROs has been all over the spectrum. Often, it's more of a black hole. We send documents, and sometimes we get a response, stating that everything has been received, but other times, we don't hear anything. But, with Activate, we know upfront exactly which documents need to be completed, and it tracks when we send them, so no one can say they never received them."

Download our white paper White Paper: More Collaboration with Investigative Sites to see how less technology overload with a workflow based system delivers transparency and efficiencies.

See how you can accelerate your clinical trials—request a FREE demonstration today.

Recent Posts